News | October 11, 2021
Sai Life Sciences presents its midterm report
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
This opens up a huge market for the company’s Magnezis implants in India
The transaction is anticipated to close in the first quarter of 2022
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
The first clinical trial is expected to commence in early 2022 both in Europe and the US
The state-of-the-art facility provides a pathway from development to large-scale biologics production
The AI-infused solution enables radiologists by fast triaging abnormalities in X-ray, annotating and automatic report generation with significantly improved performance
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
TCS to help Apoteket drive its digital transformation across sales channels and internal processes
Subscribe To Our Newsletter & Stay Updated
